title: Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.
abstract: There are currently over 2.5 million breast cancer survivors in the United States and, according to the American Cancer Society, 10 to 20 percent of these women will develop recurrent breast cancer. Early detection of recurrence can avoid unnecessary radical treatment. However, self-examination or mammography screening may not discover a recurring cancer if the number of surviving cancer cells is small, while biopsy is too invasive and cannot be frequently repeated. It is therefore important to identify non-invasive biomarkers that can detect early recurrence. The present paper develops a mathematical model of cancer recurrence. The model, based on a system of partial differential equations, focuses on tissue biomarkers that include the plasminogen system. Among them, only uPAR is known to have significant correlation to its concentration in serum and could therefore be a good candidate for serum biomarker. The model includes uPAR and other associated cytokines and cells. It is assumed that the residual cancer cells that survived primary cancer therapy are concentrated in the same location within a region with a very small diameter. Model simulations establish a quantitative relation between the diameter of the growing cancer and the total uPAR mass in the cancer. This relation is used to identify uPAR as a potential serum biomarker for breast cancer recurrence.
authors.affiliation: Mathematical Biosciences Institute, The Ohio State University, Columbus, OH, United States of America.
authors.forename: Wenrui
authors.initials: W
authors.lastname: Hao
authors.affiliation: Mathematical Biosciences Institute, The Ohio State University, Columbus, OH, United States of America.|Department of Mathematics, The Ohio State University, Columbus, OH, United States of America.
authors.forename: Avner
authors.initials: A
authors.lastname: Friedman
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000097:blood* / Q000175:diagnosis; D003198:Computer Simulation; D005260:Female; D006801:Humans; D008954:Models, Biological; D009364:Neoplasm Recurrence, Local / Q000097:blood* / Q000175:diagnosis; D011379:Prognosis; D055293:Receptors, Urokinase Plasminogen Activator / Q000097:blood*
chemical_list: D014408:Biomarkers, Tumor; D055293:Receptors, Urokinase Plasminogen Activator